Cardiff Oncology Inc. buy quelbe60
Start price
20.02.22
/
50%
€2.52
Target price
20.02.23
-
Performance (%)
-16.67%
End price
05.03.22
€2.10
Summary
This prediction ended on 05.03.22 with a price of €2.10. The prediction for Cardiff Oncology Inc. disappointed with a performance of -16.67%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 4.564% | 4.564% | -25.991% | 54.982% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by quelbe60 for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.